Literature DB >> 12716914

Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration.

Amy B Manning-Bog1, Alison L McCormack, Maya G Purisai, Laurel M Bolin, Donato A Di Monte.   

Abstract

Alpha-synuclein is likely to play a role in neurodegenerative processes, including the degeneration of nigrostriatal dopaminergic neurons that underlies Parkinson's disease. However, the toxicological properties of alpha-synuclein remain relatively unknown. Here, the relationship between alpha-synuclein expression and neuronal injury was studied in mice exposed to the herbicide paraquat. Paraquat neurotoxicity was compared in control animals versus mice with transgenic expression of human alpha-synuclein driven by the tyrosine hydroxylase (TH) promoter. In control mice, paraquat caused both the formation of alpha-synuclein-containing intraneuronal deposits and the degeneration of nigrostriatal neurons, as demonstrated by silver staining and a reduction of the counts of TH-positive and Nissl-stained cells. Mice overexpressing alpha-synuclein, either the human wild-type or the Ala53Thr mutant form of the protein, displayed paraquat-induced protein aggregates but were completely protected against neurodegeneration. These resistant animals were also characterized by increased levels of HSP70, a chaperone protein that has been shown to counteract paraquat toxicity in other experimental models and could therefore contribute to neuroprotection in alpha-synuclein transgenic mice. The results indicate a dissociation between toxicant-induced alpha-synuclein deposition and neurodegeneration. They support a role of alpha-synuclein against toxic insults and suggest that its involvement in human neurodegenerative processes may arise not only from a gain of toxic function, as previously proposed, but also from a loss of defensive properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716914      PMCID: PMC6742319     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  32 in total

1.  4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules.

Authors:  K Okada; C Wangpoengtrakul; T Osawa; S Toyokuni; K Tanaka; K Uchida
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

2.  Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine.

Authors:  N G Kholodilov; T F Oo; R E Burke
Journal:  Neurosci Lett       Date:  1999-11-12       Impact factor: 3.046

3.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

Authors:  M Vila; S Vukosavic; V Jackson-Lewis; M Neystat; M Jakowec; S Przedborski
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

5.  A Drosophila model of Parkinson's disease.

Authors:  M B Feany; W W Bender
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

6.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

7.  Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury.

Authors:  N G Kholodilov; M Neystat; T F Oo; S E Lo; K E Larsen; D Sulzer; R E Burke
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

8.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

Authors:  E Masliah; E Rockenstein; I Veinbergs; M Mallory; M Hashimoto; A Takeda; Y Sagara; A Sisk; L Mucke
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

9.  Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli.

Authors:  C A da Costa; K Ancolio; F Checler
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

10.  Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro.

Authors:  B I Giasson; K Uryu; J Q Trojanowski; V M Lee
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

View more
  82 in total

1.  Neuroprotective upregulation of endogenous α-synuclein precedes ubiquitination in cultured dopaminergic neurons.

Authors:  R E J Musgrove; A E King; T C Dickson
Journal:  Neurotox Res       Date:  2010-07-09       Impact factor: 3.911

2.  Astrocyte mediated protection of fetal cerebral cortical neurons from rotenone and paraquat.

Authors:  Mary Latha Rathinam; Lora Talley Watts; Madhusudhanan Narasimhan; Amanjot Kaur Riar; Lenin Mahimainathan; George I Henderson
Journal:  Environ Toxicol Pharmacol       Date:  2012-01-08       Impact factor: 4.860

3.  Protein aggregation in retinal cells and approaches to cell protection.

Authors:  Irina Surgucheva; Natalia Ninkina; Vladimir L Buchman; Kenneth Grasing; Andrei Surguchov
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

Review 4.  Reverse genetics for proteomics: from proteomic discovery to scientific content.

Authors:  M Bauer; M Ueffing
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

5.  Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mouse.

Authors:  Isin Unal-Cevik; Yasemin Gursoy-Ozdemir; Muge Yemisci; Sevda Lule; Gunfer Gurer; Alp Can; Veronica Müller; Philip J Kahle; Turgay Dalkara
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

6.  Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.

Authors:  Vivian P Chou; Novie Ko; Theodore R Holman; Amy B Manning-Boğ
Journal:  J Vis Exp       Date:  2014-01-07       Impact factor: 1.355

7.  Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression.

Authors:  P O Fernagut; C B Hutson; S M Fleming; N A Tetreaut; J Salcedo; E Masliah; M F Chesselet
Journal:  Synapse       Date:  2007-12       Impact factor: 2.562

Review 8.  Parkinson's disease and pesticides: a toxicological perspective.

Authors:  Jaime M Hatcher; Kurt D Pennell; Gary W Miller
Journal:  Trends Pharmacol Sci       Date:  2008-04-29       Impact factor: 14.819

9.  Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat.

Authors:  Won-Seok Choi; Shane E Kruse; Richard D Palmiter; Zhengui Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

10.  The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition.

Authors:  Virginie Loeb; Eugenia Yakunin; Ann Saada; Ronit Sharon
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.